| Literature DB >> 32722369 |
Pauline Wischhusen1, Takaya Saito2, Cécile Heraud1, Sadasivam J Kaushik1, Benoit Fauconneau1, Philip Antony Jesu Prabhu2, Stéphanie Fontagné-Dicharry1, Kaja H Skjærven2.
Abstract
Selenium is an essential micronutrient and its metabolism is closely linked to the methionine cycle and transsulfuration pathway. The present study evaluated the effect of two different selenium supplements in the diet of rainbow trout (Onchorhynchus mykiss) broodstock on the one-carbon metabolism and the hepatic DNA methylation pattern in the progeny. Offspring of three parental groups of rainbow trout, fed either a control diet (NC, basal Se level: 0.3 mg/kg) or a diet supplemented with sodium selenite (SS, 0.8 mg Se/kg) or hydroxy-selenomethionine (SO, 0.7 mg Se/kg), were collected at swim-up fry stage. Our findings suggest that parental selenium nutrition impacted the methionine cycle with lower free methionine and S-adenosylmethionine (SAM) and higher methionine synthase (mtr) mRNA levels in both selenium-supplemented treatments. DNA methylation profiling by reduced representation bisulfite sequencing (RRBS) identified differentially methylated cytosines (DMCs) in offspring livers. These DMCs were related to 6535 differentially methylated genes in SS:NC, 6890 in SO:NC and 7428 in SO:SS, respectively. Genes with the highest methylation difference relate, among others, to the neuronal or signal transmitting and immune system which represent potential targets for future studies.Entities:
Keywords: DNA methylation; methionine cycle; nutritional programming; rainbow trout; selenium; transsulfuration
Year: 2020 PMID: 32722369 PMCID: PMC7459646 DOI: 10.3390/life10080121
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Aminothiol concentrations (µg/g sample) measured in liver and oocytes of rainbow trout (Oncorhynchus mykiss) broodstock fed diets containing different levels and source of Se.
| Homocysteine | Cysteine | Cysteinyl-Glycine | Glutathione | γ-Glutamyl-Cysteine | ||
|---|---|---|---|---|---|---|
| Oocyte | NC | 0.3 ± 0.0 | 6.7 ± 1.0 | 3.7 ± 0.4 | 16 ± 1 | 1.0 ± 0.1 |
| SS | 0.3 ± 0.0 | 6.7 ± 0.6 | 4.1 ± 0.5 | 17 ± 1 | 1.0 ± 0.1 | |
| SO | 0.2 ± 0.0 | 8.1 ± 1.1 | 3.1 ± 0.3 | 13 ± 1 | 1.0 ± 0.1 | |
|
|
|
|
|
|
| |
| Female liver | NC | 1.4 ± 0.1 b | 33 ± 4 a | 53 ± 4 a | 551 ± 32 | 30 ± 4 |
| SS | 1.1 ± 0.1 b | 17 ± 2 b | 37 ± 3 b | 530 ± 32 | 23 ± 2 | |
| SO | 3.2 ± 0.3 a | 38 ± 3 a | 48 ± 3 ab | 526 ± 47 | 28 ± 3 | |
|
|
|
|
|
|
| |
| Male liver | NC | 0.7 ± 0.1 | 21 ± 3 | 26 ± 3 | 511 ± 64 | 21 ± 2 |
| SS | 1.0 ± 0.2 | 24 ± 5 | 23 ± 3 | 300 ± 66 | 10 ± 2 | |
| SO | 1.1 ± 0.3 | 33 ± 8 | 27 ± 4 | 465 ± 30 | 16 ± 5 | |
|
|
|
|
|
|
| |
| Average | Female | 1.9 ± 0.2 a | 29 ± 2 | 46 ± 2 a | 536 ± 22 a | 27 ± 2 a |
| Male | 0.9 ± 0.1 b | 26 ± 3 | 25 ± 2 b | 434 ± 39 b | 13 ± 2 b | |
|
|
|
|
|
|
| |
Values are the mean ± SEM (n = 8 in female tissue and n = 5 in males). a,b Within-rows values not sharing a common superscript letter are significantly different (p < 0.05) according to one-way ANOVA followed by Tukey’s HSD.
Free amino acid, aminothiol, and B vitamin composition of swim-up fry from broodstock fed the different diets.
| Dietary Group | NC | SS | SO | |
|---|---|---|---|---|
| Essential amino acids 1 | 1972 ± 79 a | 1737 ± 54 b | 1400 ± 65 c |
|
| Non-essential amino acids 1 | 2415 ± 50 a | 2351 ± 41 a | 2109 ± 60 b |
|
| Methionine 1 | 99 ± 5 a | 83 ± 3 b | 56 ± 4 c |
|
| Homocysteine 1 | 1.2 ± 0.1 | 1.1 ± 0.1 | 1.2 ± 0.1 | 0.86 |
| Cystathionine 1 | 9 ± 1 | 6 ± 1 | 7 ± 1 | 0.21 |
| Cysteine 1 | 21 ± 1 a | 17 ± 1 b | 17 ± 0 b |
|
| Cysteinyl-glycine 1 | 28 ± 1 a | 24 ± 1 b | 24 ± 1 b |
|
| Glutathione 1 | 179 ± 7 | 159 ± 7 | 169 ± 13 | 0.35 |
| γ-Glutamyl-cysteine 1 | 18 ± 1 | 17 ± 1 | 16 ± 1 | 0.25 |
| Taurine 1 | 688 ± 17 | 751 ± 18 | 724 ± 16 | 0.05 |
| Pyridoxamine 2 | 0.24 ± 0.01 a | 0.21 ± 0.02 b | 0.18 ± 0.01 b |
|
| Pyridoxal 2 | 1.82 ± 0.08 | 1.65 ± 0.06 | 1.85 ± 0.10 | 0.17 |
| Folate 2 | 0.36 ± 0.03 | 0.37 ± 0.02 | 0.28 ± 0.02 | 0.05 |
| Cobalamine 2 | 0.04 ± 0.00 | 0.04 ± 0.00 | 0.03 ± 0.00 | 0.51 |
1 (µg/g sample); 2 (µg/mg sample). Values are the mean ± SEM (n = 8). a,b,c Within-rows values not sharing a common superscript letter are significantly different (p < 0.05) according to one-way ANOVA followed by Tukey’s HSD.
Figure 1PCA biplot of free amino acids and related compounds measured in whole-body swim-up fry. Arrows represent the 10 most contributing variables to the model. Ellipses represent the 95% confidence intervals around a center of eight pooled samples per dietary treatment.
Figure 2(A) SAM, SAH and the SAM/SAH ratio in whole-body swim-up fry; (B) SAM, SAH and the SAM/SAH ratio in broodstock tissue. Bars are the mean ± SEM (n = 8 in swim-up fry and female tissues and n = 5 in males). Means not sharing a common superscript letter are significantly different (p < 0.05) according to one-way ANOVA followed by Tukey’s HSD.
Figure 3(A) Relative mRNA levels in whole-body swim-up fry from rainbow trout subjected to different Se treatments; (B) relative mRNA levels in parental liver tissue from rainbow trout subjected to different Se treatments. Data are normalized to β-actin and expressed as fold changes compared with the control group NC. In A, values are expressed relative to NC males. Bars are the mean ± SEM (A: n = 8; B n = 8 in female liver and n = 5 in male liver). Means not sharing a common superscript letter are significantly different (p < 0.05) according to one-way ANOVA followed by Tukey’s HSD.
Alignment statistics of 12 RRBS samples.
| No | Name | Diet | Total Reads | Uniquely Mapped | (%) | Multi-Mapped | (%) | Non-Mapped | (%) |
|---|---|---|---|---|---|---|---|---|---|
|
| PSL1 | NC | 53 987 762 | 26 310 305 | 48.7 | 19 820 505 | 36.7 | 7 856 952 | 14.6 |
|
| PSL2 | NC | 39 364 790 | 19 543 117 | 49.6 | 14 534 198 | 36.9 | 5 287 475 | 13.4 |
|
| PSL3 | NC | 54 833 812 | 27 173 708 | 49.6 | 20 233 149 | 36.9 | 7 426 955 | 13.5 |
|
| PSL4 | NC | 63 481 758 | 30 305 331 | 47.7 | 24 622 757 | 38.8 | 8 553 670 | 13.5 |
|
| PSL5 | SS | 59 570 698 | 27 527 855 | 46.2 | 23 489 555 | 39.4 | 8 553 288 | 14.4 |
|
| PSL6 | SS | 45 143 094 | 21 814 078 | 48.3 | 17 312 386 | 38.4 | 6 016 630 | 13.3 |
|
| PSL7 | SS | 67 495 806 | 31 151 354 | 46.2 | 27 389 024 | 40.6 | 8 955 428 | 13.3 |
|
| PSL8 | SO | 54 472 443 | 25 214 607 | 46.3 | 22 345 586 | 41.0 | 6 912 250 | 12.7 |
|
| PSL9 | SO | 69 558 057 | 33 562 782 | 48.3 | 26 840 717 | 38.6 | 9 154 558 | 13.2 |
|
| PSL10 | SO | 79 827 373 | 38 293 256 | 48.0 | 31 322 516 | 39.2 | 10 211 601 | 12.8 |
|
| PSL11 | SO | 55 391 941 | 25 516 081 | 46.1 | 21 796 848 | 39.4 | 8 079 012 | 14.6 |
|
| PSL12 | SS | 51 950 394 | 23 789 256 | 45.8 | 20 152 309 | 38.8 | 8 008 829 | 15.4 |
Figure 4t-SNE analysis with the CpG sites using either the > 50% or > 95% quantile.
Figure A1Clustering of the 12 RRBS samples by different algorithms. (A + B) PCA biplot by dietary treatment. (C + D) Scree plot with percentage of explained variance within the top 10 dimensions of the PCA. (E) Heatmap with sample–sample distance calculated by normalized Pearson’s correlation coefficient in a range between 0 and 1, with d = 0 as r = 1 and d=1 as r = –1. (F) Dendrogram with hierarchical clustering.
Figure 5(A) Regional distributions of mapped/original CpG. (B) Regional distributions of methylation differences of the differentially methylated cytosines (DMC) with a 20% threshold. Three violin plots show the density of overall methylation differences for SS:NC, SO:NC, and SO:SS, with scattered dots indicating DMC.
Figure 6Venn diagrams summarizing the analysis of genes with different methylation patterns in NC vs. SS, NC vs. SO and SS vs. SO. (A) Genes are included with at least one DMC in gene body or promoter region; (B) Genes are included with at least one DMC in the promoter region.
Figure A2Enriched KEGG pathways in SS:NC (A), SO:NC (B) and SO:SS (C), with the number of differentially methylated genes (DMGs).
Top five DMGs in the dataset SS:NC, with the highest number of CpG in each sub-region.
| Gene Symbol | Gene ID | Gene Name | Total DMC | DMC in the Region | Hyper-/Hypomethylated CpG | |
|---|---|---|---|---|---|---|
| Exon | LOC110496419 | 110496419 | Glycoprotein endo-alpha-1,2-mannosidase-like protein | 10 | 10 | 0/10 |
| LOC110503414 | 110503414 | TCDD-inducible poly [ADP-ribose] polymerase-like | 10 | 8 | 8/0 | |
| LOC110497587 | 110497587 | SAM and SH3 domain-containing protein 1-like, transcript variant X2 | 10 | 7 | 0/7 | |
| LOC110520294 | 110520294 | Von Willebrand factor C domain-containing protein 2-like, transcript variant X1 | 7 | 7 | 5/2 | |
| LOC110529233 | 110529233 | MAM domain—containing glycosylphosphatidylinositol anchor protein 2-like | 6 | 5 | 5/0 | |
| Intron | CTNNA2 | 110534326 | Catenin alpha-2 | 18 | 18 | 11/7 |
| alk | 110506268 | ALK receptor tyrosine kinase | 17 | 17 | 13/4 | |
|
|
|
|
|
|
| |
| NRXN2-like | 110531840 | Neurexin-2-like | 16 | 12 | 5/7 | |
| CDH4-like | 110532012 | Cadherin-4-like | 13 | 12 | 5/7 | |
| P250 |
|
|
|
|
|
|
| LOC110493563 | 110493563 | Septin-9-like | 4 | 2 | 0/2 | |
| COX6A2 | 100335037 | Cytochrome c oxidase subunit VIa | 3 | 2 | 0/2 | |
| TIMP2-like | 110487076 | Metalloproteinase inhibitor 2-like | 2 | 2 | 0/2 | |
| LOC110490026 | 110490026 | Mitogen-activated protein kinase kinase kinase 8-like | 2 | 2 | 2/0 | |
| P1K | LOC110534101 | 110534101 | Matrin-3-like | 4 | 4 | 4/0 |
| LOC110489756 | 110489756 | Transmembrane protein 14C-like | 4 | 3 | 0/3 | |
| LOC110486159 | 110486159 | Proline-rich protein 15-like protein A | 3 | 3 | 2/1 | |
| TNFR11B-like | 110506163 | Tumor necrosis factor receptor superfamily member 11B-like | 3 | 3 | 0/3 | |
| TPPP3X2-like | 110518569 | Tubulin polymerization-promoting protein family | 3 | 3 | 0/3 | |
| P6K | COX4I2-like | 110492636 | Cytochrome c oxidase subunit 4 isoform 2, mitochondrial-like | 8 | 8 | 8/0 |
| LOC110523211 | 110523211 | Oocyte zinc finger protein XlCOF6-like, transcript | 8 | 8 | 0/8 | |
| LOC110498688 | 110498688 | Fatty acid-binding protein, liver-type-like | 7 | 7 | 7/0 | |
|
|
|
|
|
|
| |
| LOC110503024 | 110503024 | Ras-related C3 botulinum toxin substrate 3-like | 5 | 4 | 0/4 |
Genes in bold are commonly highly affected also in SO:NC and SO:SS.
Top five DMGs in the dataset SO:NC, with the highest number of CpG in each sub-region.
| Gene Symbol | Gene ID | Gene Name | Total DMC | DMC in the Region | Hyper-/Hypomethylated CpG | |
|---|---|---|---|---|---|---|
| Exon | LOC110490066 | 110490066 | E3 ubiquitin-protein ligase rififylin-like, transcript variant X2 | 6 | 6 | 5/1 |
| LOC110520294 | 110520294 | von Willebrand factor C domain-containing protein 2-like, transcript variant X1 | 6 | 6 | 3/3 | |
| LOC110531157 | 110531157 | Serine/threonine-protein kinase WNK2-like | 7 | 5 | 0/5 | |
| LOC110497587 | 110497587 | SAM and SH3 domain-containing protein 1-like, transcript variant X2 | 6 | 5 | 1/4 | |
| LOC110506316 | 110506316 | Muscarinic acetylcholine receptor M4-like, transcript variant X1 | 6 | 5 | 0/5 | |
| Intron |
|
|
|
|
|
|
| LOC110505581 | 110505581 | Placenta growth factor-like | 15 | 15 | 9/6 | |
| LOC110501635 | 110501635 | Serine/threonine-protein kinase BRSK2-like | 14 | 14 | 10/4 | |
| LOC110506270 | 110506270 | Protein kinase C-binding protein NELL1-like, transcript variant X1 | 13 | 13 | 5/8 | |
| Catenin alpha-2 | 110534326 | Catenin alpha-2 | 13 | 13 | 6/7 | |
| P250 | LOC110501919 | 110501919 | Alkyldihydroxyacetonephosphatesynthase,peroxisomal-like, transcript variant X2 | 5 | 3 | 2/1 |
| LOC110494831 | 110494831 | Complement C1q-like protein 2 | 4 | 3 | 0/3 | |
| LOC110508922 | 110508922 | MARVEL domain-containing protein 2-like, transcript variant X2 | 4 | 3 | 3/0 | |
| CRIP2-like | 110505831 | Cysteine-rich protein 2-like | 3 | 3 | 3/0 | |
| LOC110497531 | 110497531 | Uncharacterized LOC110497531, transcript variant X2 | 4 | 2 | 2/0 | |
| P1K | LOC110493345 | 110493345 | Gastrula zinc finger protein XlCGF17.1-like, transcript variant X1 | 4 | 4 | 4/0 |
| LOC110521247 | 110521247 | Lactadherin-like, transcript variant X1 | 4 | 4 | 4/0 | |
| LOC110533598 | 110533598 | Ras-related protein Rab-24-like, transcript variant X1 | 4 | 4 | 0/4 | |
|
|
|
|
|
|
| |
| NFATC3-like | 110506757 | Nuclear factor of activated T-cells, cytoplasmic 3-like | 3 | 2 | 0/2 | |
| P6K |
|
|
|
|
|
|
| LOC110519930 | 110519930 | Uncharacterized LOC110519930, transcript variant X2 | 6 | 5 | 0/5 | |
| LOC110520086 | 110520086 | Collagen alpha-1(XXVIII) chain-like | 5 | 5 | 3/2 | |
| taf6l | 110531860 | TATA-box binding protein associated Factor 6 like, transcript variant X1 | 5 | 5 | 5/0 | |
| LOC110537362 | 110537362 | Glutamate receptor 3, transcript variant X3 | 5 | 5 | 5/0 |
Genes in bold commonly highly affected also in SS:NC and SO:SS.
Top five DMGs in the dataset SO:SS, with the highest number of CpG in each sub-region.
| Gene Symbol | Gene ID | Gene Name | Total DMC | DMC in the Region | Hyper-/Hypomethylated CpG | |
|---|---|---|---|---|---|---|
| Exon | CDH2-like | 110506386 | Neural-cadherin-like | 10 | 10 | 7/3 |
| PLEKHG7-like | 110497700 | Pleckstrin homology domain-Containing family G member 7-like | 9 | 9 | 0/9 | |
| NRXN2-like | 110531840 | Neurexin-2-like | 21 | 8 | 2/6 | |
| LOC110496419 | 110496419 | Glycoprotein endo-alpha-1,2-mannosidase-like protein | 8 | 8 | 8/0 | |
| LOC110496815 | 110496815 | Glutamate receptor ionotropic, kainate5-like | 8 | 7 | 7/0 | |
| Intron |
|
|
|
|
|
|
| LOC110500600 | 110500600 | Adhesion G protein-coupled receptor L3-like, transcript variant X5 | 23 | 20 | 17/3 | |
| FBXL17X1 | 110525966 | F-box and leucine rich repeat protein 17, transcript variant X2 | 18 | 16 | 13/3 | |
| LOC110535694 | 110535694 | Glutamate receptor ionotropic, delta-2, transcript variant X3 | 17 | 15 | 5/10 | |
| ZNF407-like | 110501552 | Zinc finger protein 407-like | 16 | 15 | 3/12 | |
| P250 | LOC110488021 | 110488021 | Calcitonin gene-related peptide type 1 receptor-like | 8 | 7 | 7/5 |
| GATA 2-like | 110494514 | GATA-binding factor 2-like | 7 | 6 | 6/0 | |
|
|
|
|
|
|
| |
| LOC110508922 | 110508922 | MARVEL domain-containing protein 2-like, transcript variant X2 | 3 | 3 | 3/0 | |
| CRIP2-like | 110505831 | Cysteine-rich protein 2-like | 4 | 2 | 2/0 | |
| P1K | LOC110527134 | 110527134 | Methyltransferase-like protein 7A | 5 | 5 | 0/5 |
| SEMA5A-like | 110489566 | Semaphorin-5A-like | 6 | 4 | 0/4 | |
| LOC110493345 | 110493345 | Gastrula zinc finger protein XlCGF17.1-like, transcript variant X1 | 4 | 4 | 4/0 | |
| LOC100135939 | 100135939 | Proteoglycan 4, transcript variant X2 | 4 | 4 | 1/3 | |
| GRTP1a-like | 110527156 | Growth hormone-regulated TBC Protein 1-A-like | 4 | 4 | 0/4 | |
| P6K | LOC110523211 | 110523211 | Oocyte zinc finger protein XlCOF6-like,transcript variant X2 | 8 | 8 | 8/0 |
| MARVELD2-like | 110523471 | MARVEL domain-containing protein 2-like | 8 | 8 | 8/0 | |
| MED12-like | 110488993 | Mediator of RNA polymerase II transcription subunit 12-like | 9 | 7 | 7/0 | |
| LOC110522593 | 110522593 | F-box only protein 31-like, transcript variant X1 | 7 | 7 | 0/7 | |
|
|
|
|
|
|
|
Genes in bold are commonly highly affected also in SS:NC and SO:NC.
Differentially methylated genes (DMGs) related to sulfur and selenium metabolism.
| DMGs | Hyper-/Hypomethylated DMC | |||
|---|---|---|---|---|
| Gene ID | Gene name | SS:NC | SO:NC | SO:SS |
|
| ||||
| 110530927 | S-adenosylmethionine synthase | 0/1 | ||
| 110537066 | S-adenosylmethionine synthase-like | 0/1 | 0/2 | |
| 110502651 | S-adenosylmethionine synthase-like | 1/0 P | 0/2 | 1/0 |
| 110529528 | S-adenosylmethionine decarboxylase proenzyme-like | 0/1 | 0/1 | |
| 110538418 | DNA (cytosine-5)-methyltransferase 1-like, transcript variant X1 | 0/1 | ||
| 110505844 | DNA (cytosine-5)-methyltransferase 3A-like | 1/0 | ||
| 110532515 | DNA (cytosine-5)-methyltransferase 3A-like, transcript variant X2 | 1/0 | ||
| 110497603 | DNA (cytosine-5)-methyltransferase 3A-like, transcript variant X6 | 1/0 | ||
| 110492301 | DNA (cytosine-5)-methyltransferase 3B-like, transcript variant X1 | 1/0 | ||
| 110500231 | Putative adenosylhomocysteinase 3 | 0/1 P | ||
| 110494352 | S-adenosylhomocysteine hydrolase-like protein 1 transcript variant X1 | 1/0 | ||
| 110490243 | Adenosylhomocysteinase 3-like | 2/1 | 4/2 | 0/1 |
| 110522167 | Putative adenosylhomocysteinase 3, transcript variant X2 | 0/1 | ||
|
| ||||
| 110521555 | Glutamate—cysteine ligase regulatory subunit-like | 0/1 | ||
| 110502703 | Glutamate—cysteine ligase catalytic subunit-like, transcript variant X2 | 0/1 | ||
| 110532297 | Glutathione synthetase | 0/1 P | ||
| 110522620 | Glutathione-specific gamma-glutamylcyclotransferase 1-like | 2/0 | ||
| 110537206 | Gamma-glutamyltransferase 5-like,transcript variant X1 | 0/1 P | 1/0 P | 2/0 P |
| 100305229 | Glutathione S-transferase kappa 1, transcript variant X1 | 1/0 P | ||
| 110492369 | Glucose-6-phosphate 1-dehydrogenase-like, transcript variant X2 | 2/0 | 0/1 | |
| 100305228 | Peroxiredoxin 6, transcript variant X2 | 1/0 | ||
| 110532317 | Spermidine synthase | 0/1 P | ||
| 110535309 | 5-oxoprolinase (ATP-hydrolyzing) | 0/1 | 1/2 | |
| 110501851 | Isocitrate dehydrogenase [NADP] cytoplasmic-like | 1/0 P | 0/1 P | |
| 110520228 | Isocitrate dehydrogenase [NADP] cytoplasmic-like | 1/1 | ||
|
| ||||
| 110494778 | Methionyl-tRna synthetase 1 | 0/1 | 0/1 | |
| 110488988 | Methionyl-tRNA synthetase 2, mitochondrial | 1/0 | ||
| 110500323 | Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase | 1/0 P | ||
| 110512109 | tRNA selenocysteine 1-associated protein 1-like | 0/1 | ||
| 110528137 | Eukaryotic elongation factor, selenocysteine-tRNA specific | 1/0 | ||
| 110529243 | Selenoprotein I | 0/3 | 5/0 | 7/0 |
| 100499413 | Selenoprotein U | 0/1 P | 1/0 P | 1/0 P |
| 110532070 | Selenoprotein K, transcript variant X1 | 0/1 | ||
| 110497881 | Selenoprotein O-like | 1/0 | ||
| 110525853 | Thioredoxin reductase 2 | 0/1 | ||
P located at the promoter region.
Figure 7Effect of parental Se nutrition on the methionine cycle and transsulfuration pathway in the progeny of rainbow trout. Superscript indicates that the effect was only detected in the respective treatment.
Dietary composition.
| Diet | NC | SS | SO |
|---|---|---|---|
|
| |||
| Plant meals 1 | 74 | 74 | 74 |
| Crystalline amino acids and attractant mixture 2 | 3.14 | 3.14 | 3.14 |
| Soybean lecithin3 | 2 | 2 | 2 |
| Fish oil 3 | 8 | 8 | 8 |
| Vegetable oils 4 | 8 | 8 | 8 |
| Astaxanthin (µg/g diet) 5 | 40 | 40 | 40 |
| Vitamin and mineral mixture without Se 6 | 4.82 | 4.82 | 4.82 |
| Sodium selenite (µg/g diet) 7 | – |
| – |
| Hydroxy-selenomethione (µg/g diet) 7 | – | – |
|
|
| |||
| Dry matter (DM, %) | 96 | 98 | 97 |
| Crude protein (% DM) | 49 | 50 | 50 |
| Total lipid (% DM) | 23 | 22 | 23 |
| Gross energy (kJ/g DM) | 25 | 25 | 25 |
| Ash (% DM) | 6 | 6 | 6 |
| Phosphorus (% DM) | 1.2 | 1.1 | 1.2 |
| Selenium (mg/kg dry feed) 8 |
|
|
|
1 Plant meals (% diet): 20% wheat gluten (Roquette), 18% corn gluten meal (Inzo), 15% soybean protein concentrate Estril®75 (Sopropêche), 6% soybean meal (Sud-Ouest Aliment), 5% rapeseed meal 00 (Sud-Ouest Aliment), 5% white lupin meal Farilup 500 (Terrena), 3% dehulled pea meal Primatex (Sotexpro), 2% whole wheat (Sud-Ouest Aliment). 2 Crystalline amino acids and attractant mixture (% diet): 1.34% L-lysine, 0.3% DL-methionine, 0.5% glucosamine, 0.3% taurine, 0.3% betaine, 0.2% glycine, 0.2% alanine. 3 Soybean lecithin from Louis François and fish oil from Sopropêche. 4 Vegetable oils (% diet): 4% rapeseed oil, 2.4% linseed oil, 1.6% palm oil (Daudry). 5 Provided as Carophyll® pink (DSM). 6 Vitamin and mineral mixture without Se (per kg diet): retinol acetate, 55,000 IU; cholecalciferol, 2,500 IU; DL-α-tocopherol acetate, 50 IU; sodium menadione bisulfate, 10 mg; thiamin-HCl, 1 mg; riboflavin, 4 mg; niacin, 10 mg; D-calcium pantothenate, 20 mg; pyridoxine-HCl, 3 mg; D-biotin, 0.2 mg; folic acid, 1 mg; cyanocobalamin, 10 µg; L-ascorbyl-2-polyphosphate, 50 mg; myo-inositol, 0.3 g; choline, 1 g; CaHPO4·2H2O, 33 g; CaCo3, 2.15 g; Mg(OH)2, 1.24 g; KCl, 0.9 g; NaCl, 0.4 g; FeSO4·7H2O, 0.2 g; ZnSO4·7H2O, 40 mg; MnSO4·H2O, 30 mg; CuSO4·5H2O, 30 mg; NaF, 10 mg; KI, 0.4 mg; CoCl2·6H2O, 0.2 mg. All ingredients were diluted with α-cellulose. 7 Sodium selenite contained 42% Se (Sigma-Aldrich) and hydroxy-selenomethionine contained 40% Se provided as Selisseo® (Adisseo). 8 Total Se was determined using inductively coupled plasma mass spectrometry (ICP MS, Agilent series 7500cx) by Ultra-Trace Analysis Aquitaine (UT2A, Pau, France) according to Vacchina and Dumont [51], with a calculated uncertainty of 15 µg/kg and a limit of quantification of 3 µg/kg.
Oligonucleotide primers used to assay mRNA levels by Fluidigm PCR.
| Gene | Accession No. | Forward Primer | Reverse Primer | Amplification Size |
|---|---|---|---|---|
|
| XM_021611778.1 | ccgtaccatcccaaggtttga | tcctgcttgtcggtctttgt | 87 |
|
| XM_021600287.1 | cagccagattttcccaaacgg | gcatgctcgttctcccagaa | 108 |
|
| FR908041.1 | cagagaagcacggtaactgg | ttctttgtgctgcatcaggt | 188 |
|
| NM_001124686.1 | ccacctcaggcaatacaggt | aacatccaccttctccatgc | 107 |
|
| EU315111.1 | caccaaccccaccatgaaag | gcgctggaagtaggctgaca | 118 |
|
| XM_021557911.1 | ttgccagaagaggagatgcc | cccaggtcagcttgccatta | 152 |
|
| XM_021585680.1 | ctcaagtacgcgctgaagga | cactctggtcccctttgaagt | 187 |
|
| XM_021576690.1 | aatgcaggtctgcccaatac | ctgatgtgtgcaggagtcgt | 137 |
|
| XM_021609053.1 | atcaaacgggccacagatgt | tcgtaccttccatggcagc | 167 |
|
| AJ438158.1 | gatgggccgaaagacagcta | tcgtcccgtggtgacgat | 105 |
amd1, adenosylmethionine decarboxylase 1; bhmt, betaine-homocysteine S-methyltransferase 1; cbs, cystathionine beta-synthase; cgl, cystathionine gamma-lyase; dnmt1, DNA methyltransferase 1; gnmt, glycine N-methyltransferase; mtr, methionine synthase; sahh, adenosylhomocysteinase.